Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124060022 | 12406002 | 2 | F | 20160516 | 20160713 | 20160526 | 20160720 | EXP | JP-ROCHE-1763898 | ROCHE | 79.23 | YR | F | Y | 0.00000 | 20160720 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124060022 | 12406002 | 1 | PS | ALECENSA | ALECTINIB HYDROCHLORIDE | 1 | Oral | U | 208434 | 300 | MG | COATED TABLET | BID | ||||||
| 124060022 | 12406002 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 124060022 | 12406002 | 3 | SS | AZULFIDINE EN-TABS | SULFASALAZINE | 1 | Oral | DOSAGE IS UNCERTAIN | U | 0 | 500 | MG | TABLET | BID | |||||
| 124060022 | 12406002 | 4 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | U | 0 | 2 | MG | CAPSULE | BID | ||||||
| 124060022 | 12406002 | 5 | SS | LOSARTAN K | LOSARTAN POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 124060022 | 12406002 | 6 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 124060022 | 12406002 | 7 | SS | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124060022 | 12406002 | 1 | Lung adenocarcinoma |
| 124060022 | 12406002 | 2 | Product used for unknown indication |
| 124060022 | 12406002 | 3 | Product used for unknown indication |
| 124060022 | 12406002 | 4 | Product used for unknown indication |
| 124060022 | 12406002 | 5 | Product used for unknown indication |
| 124060022 | 12406002 | 6 | Product used for unknown indication |
| 124060022 | 12406002 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124060022 | 12406002 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124060022 | 12406002 | Neutrophil count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124060022 | 12406002 | 1 | 20160506 | 0 | ||
| 124060022 | 12406002 | 3 | 20160518 | 0 | ||
| 124060022 | 12406002 | 4 | 20160518 | 0 |